measuregroup/AID1806959

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID475725353_AID1806959_PMID_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID475725353_AID1806959_PMID_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID475725354_AID1806959_PMID_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID475725357_AID1806959_PMID_VALUE9 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID475725352_AID1806959_PMID_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID475725355_AID1806959_PMID_VALUE8 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID475725354_AID1806959_PMID_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID475725352_AID1806959_PMID_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID475725357_AID1806959_PMID_VALUE10 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID475725355_AID1806959_PMID_VALUE7
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP34972 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21554
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title	In Vitro Binding to CB1 and CB2 Receptors from US Patent US11485700: \"Synthesis of (+)-cannabinoids and their therapeutic effects\"
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID475725357 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID475725354 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID475725355 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID475725352 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID475725353
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1806959

Total number of triples: 21.